Description
NKP-1339, aslo known as IT-139 and KP-1339, is a ruthenium-based anticancer drug in clinical development against solid cancer with limited side effects. NKP-1339 shows promising results in solid tumors, such as non-small cell lung cancer, colorectal carcinoma, and most distinctively in gastrointestinal neuroendocrine tumors.
Product information
CAS Number: 197723-00-5
Molecular Weight: 502.14
Formula: C14H12Cl4N4NaRu
Synonym:
IT-139
KP-1339
Chemical Name: sodium bis(1H-indazole) tetrachlororutheniumuide
Smiles: [Na+].Cl[Ru-](Cl)(Cl)Cl.C1=NNC2=CC=CC=C21.C1=NNC2=CC=CC=C21
InChiKey: WVVOCRYXBTVDRN-UHFFFAOYSA-J
InChi: InChI=1S/2C7H6N2.4ClH.Na.Ru/c2*1-2-4-7-6(3-1)5-8-9-7;;;;;;/h2*1-5H,(H,8,9);4*1H;;/q;;;;;;+1;+3/p-4
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.